GLP1R and metabolic syndrome: Due to its ability to act on numerous pathways that can regulate glycaemia, weight, lipid metabolism, and blood pressure (Figure 2) (1, 29), as further outlined below, GLP-1R agonists, have been implicated and implemented as a potential therapy to address the increasingly prevalent pathologies associated with metabolic syndrome.